speb/financial-data huggingface dataset:
Financial ratios for ALHIT.PA — annual report dated 2021-12-31
Capital expenditures: 0
Buffett classification: The Gruesome
Stock price: 13.068181818181818
Shares outstanding: 1661315
Market cap (USD): 21710366.477272727
Buyback yield (%): 0
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for ALHIT.PA — annual report dated 2022-12-31
Total revenue: 29168473.191489365
Gross profit: 3596960.425531915
Operating income: 3034475.3191489363
Net income: 2322377.659574468
Capital expenditures: 0
Depreciation & amortization: 76298.93617021276
Net tangible assets: 5267374.468085106
Owner earnings: 2398676.595744681
Return on net tangible assets (%): 45.53837230062537
Capex to operating income (%): 0
Buffett classification: The Great
Stock price: 11.787234042553193
P/E ratio: 8.43200874012556
Shares outstanding: 1661315
Book value: 5879102.127659574
P/B ratio: 3.3308332289848868
Market cap (USD): 19582308.72340426
Debt to equity: 0.05749487003732659
Current ratio: 1.8032058932689294
Quick ratio: 1.8032058932689294
Effective tax rate (%): 25.382217736188156
Interest coverage ratio: 1227.897890658631
COGS to revenue (%): 87.66832805434115
Buyback yield (%): 0
Retained earnings: 3962978.7234042557
Receivables turnover: 6.02241535223237
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 40.61992083093202
Rule of 40 score: 0
Financial ratios for ALHIT.PA — annual report dated 2023-12-31
Total revenue: 34332735.55555555
Gross profit: 4033704.4444444445
Operating income: 3176835.5555555555
Net income: 2514616.6666666665
Capital expenditures: 0
Depreciation & amortization: 103676.66666666666
Net tangible assets: 5682366.666666667
Owner earnings: 2618293.333333333
Return on net tangible assets (%): 46.07751465058572
Capex to operating income (%): 0
Buffett classification: The Great
Stock price: 14.78888888888889
P/E ratio: 9.77047645874896
Shares outstanding: 1661315
Book value: 6372992.222222222
P/B ratio: 3.8551754164666767
Market cap (USD): 24569002.944444444
Debt to equity: 0.028556619051961114
Current ratio: 1.8220859370355378
Quick ratio: 1.8220859370355378
Effective tax rate (%): 26.11771918107374
Interest coverage ratio: 618.4624702574085
COGS to revenue (%): 88.2511417189076
Buyback yield (%): 0
Retained earnings: 4371707.777777778
Receivables turnover: 7.102810256268799
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 40.377115484556114
Revenue growth (%): 17.704945782259838
Rule of 40 score: 17.704945782259838
Financial ratios for ALHIT.PA — annual report dated 2024-12-31
Total revenue: 28560623.958333336
Gross profit: 3152482.291666667
Operating income: 2327064.5833333335
Net income: 1886271.875
Capital expenditures: 0
Depreciation & amortization: 108792.70833333334
Net tangible assets: 4915870.833333334
Owner earnings: 1995064.5833333333
Return on net tangible assets (%): 40.58415387575446
Capex to operating income (%): 0
Buffett classification: The Great
Stock price: 14.239583333333334
P/E ratio: 12.541369936619908
Shares outstanding: 1661315
Book value: 5642559.375000001
P/B ratio: 4.192500568133883
Market cap (USD): 23656433.385416668
Debt to equity: 0.004605991998681154
Current ratio: 1.6254758813968062
Quick ratio: 1.6254758813968062
Effective tax rate (%): 26.273705504119825
Interest coverage ratio: 4397.602362204724
COGS to revenue (%): 88.96213788513242
Buyback yield (%): 0
Retained earnings: 3766355.2083333335
Receivables turnover: 7.410987036948441
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 38.40772066737132
Revenue growth (%): -16.812268244346765
Rule of 40 score: -16.812268244346765
Financial ratios for ALHIT.PA — quarterly report dated 2024-12-31
Capital expenditures: 0
Net tangible assets: 4915870.833333334
Buffett classification: The Gruesome
Stock price: 14.239583333333334
Shares outstanding: 1661315
Book value: 5642559.375000001
P/B ratio: 4.192500568133883
Market cap (USD): 23656433.385416668
Debt to equity: 0.004605991998681154
Current ratio: 1.6254758813968062
Quick ratio: 1.6254758813968062
Buyback yield (%): 0
Retained earnings: 3766355.2083333335
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for ALLUX.PA — annual report dated 2021-12-31
Capital expenditures: 0
Buffett classification: The Gruesome
Stock price: 415.42045454545456
Shares outstanding: 279411
Market cap (USD): 116073044.625
Buyback yield (%): 0
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for ALLUX.PA — annual report dated 2022-12-31
Total revenue: 173736170.21276596
Gross profit: 78414893.61702128
Operating income: 9722340.425531916
Net income: 6991489.361702128
Capital expenditures: 3302127.659574468
Operating cash flow: -1011702.1276595745
Depreciation & amortization: 8369148.936170213
Net tangible assets: 114622340.42553192
Owner earnings: 12058510.638297874
Return on net tangible assets (%): 10.52020975451297
Capex to operating income (%): 33.96432870117081
Buffett classification: The Good
Stock price: 353.44680851063833
P/E ratio: 14.125305940353012
Shares outstanding: 279411
Book value: 117744680.85106385
P/B ratio: 0.8387378988073726
Market cap (USD): 98756926.21276596
Debt to equity: 0.1440639681966028
Current ratio: 3.298944675407739
Quick ratio: 2.127886152862168
Effective tax rate (%): 26.540778498609818
Interest coverage ratio: 58.58333333333334
COGS to revenue (%): 54.86553345743117
Free cash flow (dilution-adjusted): -4955319.14893617
Buyback yield (%): 0.7960658992891296
Inventory turnover: 2.446871842486141
Receivables turnover: 5.845724308265025
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 7.254671598901361
FCF margin (%): -2.852209268149309
Rule of 40 score: -2.852209268149309
Financial ratios for ALLUX.PA — annual report dated 2023-12-31
Total revenue: 166231111.1111111
Gross profit: 82236666.66666667
Operating income: 9451111.11111111
Net income: 7244444.444444444
Capital expenditures: 4126666.6666666665
Operating cash flow: 24347777.777777776
Depreciation & amortization: 8700000
Net tangible assets: 124386666.66666666
Owner earnings: 11817777.777777778
Return on net tangible assets (%): 9.500839675563654
Capex to operating income (%): 43.66329649659064
Buffett classification: The Good
Stock price: 279.5777777777778
P/E ratio: 10.783036168711657
Shares outstanding: 279411
Book value: 127683333.33333334
P/B ratio: 0.6118034705652003
Market cap (USD): 78117106.46666667
Debt to equity: 0.19905147282774224
Current ratio: 3.258463735348367
Quick ratio: 2.401648122805974
Effective tax rate (%): 26.432489205274827
Interest coverage ratio: 12.946727549467274
COGS to revenue (%): 50.52871504197637
Free cash flow (dilution-adjusted): 19418888.888888888
Buyback yield (%): 0.19770886484428019
Inventory turnover: 2.6247352522481857
Receivables turnover: 5.5792653365653555
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 6.233785269329424
FCF margin (%): 11.681861932516977
Revenue growth (%): -4.31980231431589
Rule of 40 score: 7.362059618201087
Financial ratios for ALLUX.PA — annual report dated 2024-12-31
Total revenue: 153773958.33333334
Gross profit: 80271875
Operating income: 11961458.333333334
Net income: 8857291.666666668
Capital expenditures: 2483333.3333333335
Operating cash flow: 20596875
Depreciation & amortization: 8517708.333333334
Net tangible assets: 114543750
Owner earnings: 14891666.666666666
Return on net tangible assets (%): 13.000854840763173
Capex to operating income (%): 20.761125141513542
Buffett classification: The Great
Stock price: 353.1458333333333
P/E ratio: 11.14029368693402
Shares outstanding: 279411
Book value: 126311458.33333334
P/B ratio: 0.7811866931114391
Market cap (USD): 98672830.4375
Debt to equity: 0.16065611624704146
Current ratio: 3.0367311850366008
Quick ratio: 2.290410816161721
Effective tax rate (%): 25.167194649771208
Interest coverage ratio: 12.414054054054054
COGS to revenue (%): 47.79878474221497
Free cash flow (dilution-adjusted): 17498958.333333336
Buyback yield (%): 0.07389741060772809
Inventory turnover: 2.4629830011518727
Receivables turnover: 5.019653847461662
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 7.942590351028878
FCF margin (%): 11.379663060634183
Revenue growth (%): -7.4938756617293105
Rule of 40 score: 3.8857873989048723
Financial ratios for ALLUX.PA — quarterly report dated 2024-12-31
Capital expenditures: 0
Net tangible assets: 114543750
Buffett classification: The Gruesome
Stock price: 353.1458333333333
Shares outstanding: 279411
Book value: 126311458.33333334
P/B ratio: 0.7811866931114391
Market cap (USD): 98672830.4375
Debt to equity: 0.16065611624704146
Current ratio: 3.0367311850366008
Quick ratio: 2.290410816161721
Buyback yield (%): 0
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for ARW — annual report dated 2021-12-31
Capital expenditures: 0
Buffett classification: The Gruesome
Stock price: 134.27
Shares outstanding: 51133946
Market cap (USD): 6865754929.42
Buyback yield (%): 0
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for ARW — annual report dated 2022-12-31
Total revenue: 37124422000
Gross profit: 4836625000
Operating income: 2082235000
Net income: 1435158000
Capital expenditures: 78836000
Operating cash flow: -33077000
Depreciation & amortization: 187382000
Net tangible assets: 3359594000
Owner earnings: 1543704000
Return on net tangible assets (%): 45.949123614341495
Capex to operating income (%): 3.786124044596311
Buffett classification: The Great
Stock price: 104.57
P/E ratio: 3.7257756520327376
Shares outstanding: 51133946
Book value: 5611353000
P/B ratio: 0.9529032896736312
Market cap (USD): 5347076733.219999
Debt to equity: 0.6723595895677923
Current ratio: 1.4803007424611796
Quick ratio: 1.0509594172662822
Effective tax rate (%): 23.829949844757582
Interest coverage ratio: 11.216037878134966
COGS to revenue (%): 86.9718510364956
SG&A to revenue (%): 6.914607316983952
Free cash flow (dilution-adjusted): -154843000
Buyback yield (%): 19.627303896347883
Retained earnings: 9214832000
Inventory turnover: 6.0698547139707735
Receivables turnover: 3.012681537683613
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 22.21387606738857
FCF margin (%): -0.4170920156009433
Rule of 40 score: -0.4170920156009433
Financial ratios for ARW — annual report dated 2023-12-31
Total revenue: 33107120000
Gross profit: 4149018000
Operating income: 1555080000
Net income: 909363000
Capital expenditures: 83285000
Operating cash flow: 705449000
Depreciation & amortization: 181116000
Net tangible assets: 3627598000
Owner earnings: 1007194000
Return on net tangible assets (%): 27.764763350294054
Capex to operating income (%): 5.355673020037555
Buffett classification: The Great
Stock price: 122.25
P/E ratio: 6.874179946292076
Shares outstanding: 51133946
Book value: 5877307000
P/B ratio: 1.0636036025513047
Market cap (USD): 6251124898.5
Debt to equity: 0.6478319066878759
Current ratio: 1.3897208225368072
Quick ratio: 0.9963881999568694
Effective tax rate (%): 21.899783055668635
Interest coverage ratio: 4.730655504313649
COGS to revenue (%): 87.46789814396419
SG&A to revenue (%): 7.287924772677297
Free cash flow (dilution-adjusted): 580595000
Buyback yield (%): 12.320982423256568
Retained earnings: 5790217000
Inventory turnover: 5.582580666926922
Receivables turnover: 2.7052559663600633
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 18.21302734835243
FCF margin (%): 1.7536862161371933
Revenue growth (%): -10.82118396348366
Rule of 40 score: -9.067497747346467
Financial ratios for ARW — quarterly report dated 2024-09-30
Capital expenditures: 0
Buffett classification: The Gruesome
Stock price: 132.83
Shares outstanding: 51133946
Market cap (USD): 6792122047.18
Buyback yield (%): 0
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for ARW — quarterly report dated 2024-12-31
Capital expenditures: 0
Buffett classification: The Gruesome
Stock price: 113.12
Shares outstanding: 51133946
Market cap (USD): 5784271971.52
Buyback yield (%): 0
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for ARW — annual report dated 2024-12-31
Total revenue: 27923324000
Gross profit: 3292408000
Operating income: 911474000
Net income: 393507000
Capital expenditures: 87546000
Operating cash flow: 1130413000
Depreciation & amortization: 162994000
Net tangible assets: 3609150000
Owner earnings: 468955000
Return on net tangible assets (%): 12.993502625271876
Capex to operating income (%): 9.604881762946611
Buffett classification: The Great
Stock price: 113.12
P/E ratio: 14.699286090260149
Shares outstanding: 51133946
Book value: 5831528000
P/B ratio: 0.9918964586159923
Market cap (USD): 5784271971.52
Debt to equity: 0.5356676672048903
Current ratio: 1.4562501652004778
Quick ratio: 1.0835336710624635
Effective tax rate (%): 19.580682540428636
Interest coverage ratio: 3.377906416537575
COGS to revenue (%): 88.20911149403273
SG&A to revenue (%): 7.942965529462037
Free cash flow (dilution-adjusted): 1003079000
Buyback yield (%): 4.583843935857074
Retained earnings: 5980826000
Inventory turnover: 5.229820290268649
Receivables turnover: 2.142839635143636
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 9.992539641036688
FCF margin (%): 3.592262153316704
Revenue growth (%): -15.657647055980709
Rule of 40 score: -12.065384902664004
Financial ratios for ARW — quarterly report dated 2025-03-31
Total revenue: 6814017000
Gross profit: 773992000
Operating income: 175866000
Net income: 79864000
Capital expenditures: 24979000
Operating cash flow: 351679000
Depreciation & amortization: 35810000
Net tangible assets: 3754898000
Owner earnings: 90695000
Return on net tangible assets (%): 2.4153785269266965
Capex to operating income (%): 14.203427609657352
Buffett classification: The Great
Stock price: 103.83
P/E ratio: 16.61962089671191
Shares outstanding: 51133946
Book value: 5997417000
P/B ratio: 0.8852540373930977
Market cap (USD): 5309237613.18
Debt to equity: 0.4741187747992177
Current ratio: 1.4307973888196464
Quick ratio: 1.050050797284083
Effective tax rate (%): 22.619151430592293
Interest coverage ratio: 3.1302908404827168
COGS to revenue (%): 88.64117891105936
SG&A to revenue (%): 8.25234219403914
Free cash flow (dilution-adjusted): 308141000
Buyback yield (%): 1.1190495571814165
Retained earnings: 6060546000
Inventory turnover: 1.2587153695804347
Receivables turnover: 0.5484720856657492
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 1.9989756537027528
FCF margin (%): 4.522163651778385
Rule of 40 score: 4.522163651778385
Financial ratios for ARW — quarterly report dated 2025-06-30
Total revenue: 7579947000
Gross profit: 848657000
Operating income: 212505000
Net income: 187749000
Capital expenditures: 18618000
Operating cash flow: -205896000
Depreciation & amortization: 35162000
Net tangible assets: 4123344000
Owner earnings: 204293000
Return on net tangible assets (%): 4.954546601011218
Capex to operating income (%): 8.761205618691324
Buffett classification: The Great
Stock price: 127.43
P/E ratio: 24.34858821798642
Shares outstanding: 51133946
Book value: 6409074000
P/B ratio: 1.0166833365912142
Market cap (USD): 6515998738.780001
Debt to equity: 0.4402233458374798
Current ratio: 1.3917786701230543
Quick ratio: 1.0746903278071456
Effective tax rate (%): 19.71788663953708
Interest coverage ratio: 3.5251231690526352
COGS to revenue (%): 88.80391907753445
SG&A to revenue (%): 7.928683406361549
Free cash flow (dilution-adjusted): -236155000
Buyback yield (%): 0.7786373514476672
Retained earnings: 6248295000
Inventory turnover: 1.417283459850243
Receivables turnover: 0.4963508462808361
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 2.291327019123774
FCF margin (%): -3.115523103261804
Revenue growth (%): 11.24050615077714
Rule of 40 score: 8.124983047515336
Financial ratios for ARW — quarterly report dated 2025-09-30
Total revenue: 7712541000
Gross profit: 835314000
Operating income: 214655000
Net income: 109262000
Capital expenditures: 30276000
Operating cash flow: -281684000
Depreciation & amortization: 32793000
Net tangible assets: 4201928000
Owner earnings: 111779000
Return on net tangible assets (%): 2.660183610951925
Capex to operating income (%): 14.10449325662109
Buffett classification: The Great
Stock price: 121
P/E ratio: 16.41713423814262
Shares outstanding: 51133946
Book value: 6475619000
P/B ratio: 0.9554619359168598
Market cap (USD): 6187207466
Debt to equity: 0.48327210109180296
Current ratio: 1.4636853280763837
Quick ratio: 1.13630234662008
Effective tax rate (%): 15.162667908999145
Interest coverage ratio: 3.9117084282460137
COGS to revenue (%): 89.16940603622075
SG&A to revenue (%): 7.62220907480427
Free cash flow (dilution-adjusted): -302208000
Buyback yield (%): 0.010182299582840592
Retained earnings: 6357488000
Inventory turnover: 1.454570854424831
Receivables turnover: 0.4925995809109592
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 2.12853134361688
FCF margin (%): -3.9183973219720976
Revenue growth (%): 1.7492734447879386
Rule of 40 score: -2.169123877184159
Financial ratios for ARW — quarterly report dated 2025-12-31
Total revenue: 8746430000
Gross profit: 1008756000
Operating income: 335316000
Net income: 194604000
Capital expenditures: 27381000
Operating cash flow: 199950000
Depreciation & amortization: 33985000
Net tangible assets: 4387619000
Owner earnings: 201208000
Return on net tangible assets (%): 4.585812943193108
Capex to operating income (%): 8.165730236552983
Buffett classification: The Great
Stock price: 110.18
P/E ratio: 9.858521783442612
Shares outstanding: 51133946
Book value: 6658699000
P/B ratio: 0.8461019442807072
Market cap (USD): 5633938170.280001
Debt to equity: 0.46331212748916867
Current ratio: 1.3616072740941847
Quick ratio: 1.0919465855802037
Effective tax rate (%): 23.4914397979231
Interest coverage ratio: 7.661913901837126
COGS to revenue (%): 88.46665439499316
SG&A to revenue (%): 7.311040047196399
Free cash flow (dilution-adjusted): 165134000
Buyback yield (%): 0.9032757985959726
Retained earnings: 6552092000
Inventory turnover: 1.5226057845321685
Receivables turnover: 0.44311150510373903
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 3.2768935788459395
FCF margin (%): 1.8880160248238422
Revenue growth (%): 13.405296646072934
Rule of 40 score: 15.293312670896777
Financial ratios for ARW — annual report dated 2025-12-31
Total revenue: 30852935000
Gross profit: 3466719000
Operating income: 938342000
Net income: 571266000
Capital expenditures: 101254000
Operating cash flow: 64049000
Depreciation & amortization: 137750000
Net tangible assets: 4387619000
Owner earnings: 607762000
Return on net tangible assets (%): 13.851749661946492
Capex to operating income (%): 10.79073514773931
Buffett classification: The Great
Stock price: 110.18
P/E ratio: 9.862197593205266
Shares outstanding: 51133946
Book value: 6658699000
P/B ratio: 0.8461019442807072
Market cap (USD): 5633938170.280001
Debt to equity: 0.46331212748916867
Current ratio: 1.3616072740941847
Quick ratio: 1.0919465855802037
Effective tax rate (%): 20.64747439854693
Interest coverage ratio: 4.362271273430527
COGS to revenue (%): 88.76373025775344
SG&A to revenue (%): 7.748458939157652
Free cash flow (dilution-adjusted): -65088000
Buyback yield (%): 2.8695558082769166
Retained earnings: 6552092000
Inventory turnover: 5.389011077236832
Receivables turnover: 1.5630709289067457
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 9.169997478681175
FCF margin (%): -0.2109621013365503
Revenue growth (%): 10.4916269997082
Rule of 40 score: 10.28066489837165
Financial ratios for ASPI — annual report dated 2022-12-31
Total revenue: 0
Gross profit: 0
Operating income: -5099048
Net income: -4945139
Capital expenditures: 4473164
Operating cash flow: -2939893
Depreciation & amortization: 0
Net tangible assets: 9817461
Owner earnings: -9418303
Return on net tangible assets (%): -95.9342033546148
Buffett classification: The Gruesome
Stock price: 1.58
Shares outstanding: 125903447
Book value: 9817461
P/B ratio: 20.26261639949474
Market cap (USD): 198927446.26000002
Debt to equity: 0.08374874114600506
Current ratio: 1.7053354204097273
Quick ratio: 1.7053354204097273
Free cash flow (dilution-adjusted): -9412370
Buyback yield (%): 0
Retained earnings: -7553066
Capitalized R&D asset: 1273536
ROCI (R&D-adjusted, %): -35.915372030449305
Rule of 40 score: 0
Financial ratios for ASPI — annual report dated 2023-12-31
Total revenue: 433026
Gross profit: 138970
Operating income: -16041999
Net income: -16286234
Capital expenditures: 2331343
Operating cash flow: -5412392
Depreciation & amortization: 37433
Net tangible assets: 13028851
Owner earnings: -18580144
Return on net tangible assets (%): -142.60769426252554
Buffett classification: The Gruesome
Stock price: 1.79
Shares outstanding: 125903447
Book value: 18830631
P/B ratio: 11.968115679713547
Market cap (USD): 225367170.13
Debt to equity: 0.11378482218678705
Current ratio: 1.8523653212524223
Quick ratio: 1.8523653212524223
Interest coverage ratio: -135.32184703113532
COGS to revenue (%): 67.90723882630604
R&D to revenue (%): 176.56699597714686
SG&A to revenue (%): 3560.152970029513
Free cash flow (dilution-adjusted): -16487534
Buyback yield (%): 0
Retained earnings: -23839300
Receivables turnover: 0.461622596615113
Capitalized R&D asset: 1617850.12
ROCI (R&D-adjusted, %): -67.94229538976099
Rosenberg metric: 0.10912137544600231
FCF margin (%): -3807.515945924725
Rule of 40 score: -3807.515945924725
Financial ratios for ASPI — quarterly report dated 2024-09-30
Capital expenditures: 0
Buffett classification: The Gruesome
Stock price: 2.78
Shares outstanding: 125903447
Market cap (USD): 350011582.65999997
Buyback yield (%): 0
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for ASPI — quarterly report dated 2024-12-31
Capital expenditures: 0
Buffett classification: The Gruesome
Stock price: 4.53
Shares outstanding: 125903447
Market cap (USD): 570342614.9100001
Buyback yield (%): 0
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for ASPI — annual report dated 2024-12-31
Total revenue: 4144000
Gross profit: 1599000
Operating income: -26354000
Net income: -32334000
Capital expenditures: 11372000
Operating cash flow: -16696000
Depreciation & amortization: 471000
Net tangible assets: 44731000
Owner earnings: -43235000
Return on net tangible assets (%): -96.65556325590754
Buffett classification: The Gruesome
Stock price: 4.53
Shares outstanding: 125903447
Book value: 51167000
P/B ratio: 11.146688586589013
Market cap (USD): 570342614.9100001
Debt to equity: 0.7376824906678132
Current ratio: 9.313500495820938
Quick ratio: 9.304150729565094
Interest coverage ratio: -101.75289575289575
COGS to revenue (%): 61.41409266409267
R&D to revenue (%): 75.7480694980695
SG&A to revenue (%): 598.7934362934362
Free cash flow (dilution-adjusted): -36629000
Buyback yield (%): 0
Retained earnings: -56173000
Inventory turnover: 38.56060606060606
Receivables turnover: 1.793939393939394
Capitalized R&D asset: 4071536.15
ROCI (R&D-adjusted, %): -27.299211144862205
Rosenberg metric: 1.909581849405099
FCF margin (%): -883.9044401544401
Revenue growth (%): 856.9864165200241
Rule of 40 score: -26.91802363441593
Financial ratios for ASPI — quarterly report dated 2025-03-31
Total revenue: 1102000
Gross profit: 327000
Operating income: -7952000
Net income: -8446000
Capital expenditures: 2359000
Operating cash flow: -3170000
Depreciation & amortization: 149000
Net tangible assets: 39250497
Owner earnings: -10656000
Return on net tangible assets (%): -27.14870081772468
Buffett classification: The Gruesome
Stock price: 4.69
Shares outstanding: 125903447
Book value: 45727106
P/B ratio: 12.913285315497554
Market cap (USD): 590487166.4300001
Debt to equity: 0.8408219842296601
Current ratio: 7.211775727722262
Quick ratio: 7.169906994888953
Interest coverage ratio: -91.40229885057471
COGS to revenue (%): 70.32667876588022
R&D to revenue (%): 138.83847549909257
SG&A to revenue (%): 612.431941923775
Free cash flow (dilution-adjusted): -7419000
Buyback yield (%): 0
Retained earnings: -64619078
Inventory turnover: 2.2615323559622746
Receivables turnover: 1.5919265344683875
Capitalized R&D asset: 1530000
ROCI (R&D-adjusted, %): -8.230937400705116
FCF margin (%): -673.2304900181489
Rule of 40 score: -673.2304900181489
Financial ratios for ASPI — quarterly report dated 2025-06-30
Total revenue: 1198345
Gross profit: 572098
Operating income: -11968586
Net income: -75062857
Capital expenditures: 1748564
Operating cash flow: -7901311
Depreciation & amortization: 529959
Net tangible assets: 21869309
Owner earnings: -76281462
Return on net tangible assets (%): -348.8060002261617
Buffett classification: The Gruesome
Stock price: 7.36
Shares outstanding: 125903447
Book value: 28311060
P/B ratio: 32.73100229804182
Market cap (USD): 926649369.9200001
Debt to equity: 3.59183866658472
Current ratio: 14.715291483386714
Quick ratio: 14.563832556371667
Interest coverage ratio: -146.30986638631836
COGS to revenue (%): 52.25932431812208
R&D to revenue (%): 73.42835327055231
SG&A to revenue (%): 973.0719450575587
Free cash flow (dilution-adjusted): -14079253
Buyback yield (%): 0
Retained earnings: -139681935
Inventory turnover: 0.5989286657000876
Receivables turnover: 0.03861948097405354
Capitalized R&D asset: 1905025
ROCI (R&D-adjusted, %): -9.083669653530388
Rosenberg metric: 0.16019477124183007
FCF margin (%): -1174.891454464282
Revenue growth (%): 8.742740471869329
Rule of 40 score: -1166.1487139924127
Financial ratios for ASPI — quarterly report dated 2025-09-30
Total revenue: 4889526
Gross profit: 423178
Operating income: -14966939
Net income: -12874007
Capital expenditures: 3148212
Operating cash flow: -8857647
Depreciation & amortization: 296316
Net tangible assets: 66028836
Owner earnings: -15725903
Return on net tangible assets (%): -23.816720016085092
Buffett classification: The Gruesome
Stock price: 9.62
Shares outstanding: 125903447
Book value: 96603977
P/B ratio: 12.537694593463787
Market cap (USD): 1211191160.1399999
Debt to equity: 1.1765205380726718
Current ratio: 6.1448383562526
Quick ratio: 6.096407723718116
Interest coverage ratio: -102.47397573533439
COGS to revenue (%): 91.34521423958068
R&D to revenue (%): 63.37029397123566
SG&A to revenue (%): 251.38653521834223
Free cash flow (dilution-adjusted): -16489667
Buyback yield (%): 0
Retained earnings: -152555942
Inventory turnover: 3.2559774534204053
Receivables turnover: 0.09752800776262566
Capitalized R&D asset: 4192956.75
ROCI (R&D-adjusted, %): -6.792535769460667
Rosenberg metric: -0.16924169673551723
FCF margin (%): -337.2446940664596
Revenue growth (%): 308.0232320408563
Rule of 40 score: -29.221462025603273
Financial ratios for ASPI — quarterly report dated 2025-12-31
Total revenue: 16659524
Gross profit: 2082884
Operating income: -22303139
Net income: -63330807
Capital expenditures: 2398224
Operating cash flow: -17851042
Depreciation & amortization: 936725
Net tangible assets: 194103000
Owner earnings: -64792306
Return on net tangible assets (%): -33.38037330695558
Buffett classification: The Gruesome
Stock price: 5.35
Shares outstanding: 125903447
Book value: 262898000
P/B ratio: 2.562147454335902
Market cap (USD): 673583441.4499999
Debt to equity: 0.8214592731781908
Current ratio: 12.231435037925129
Quick ratio: 12.197852948372889
Interest coverage ratio: -85.78460325397131
COGS to revenue (%): 87.4973378591129
R&D to revenue (%): 41.11625878386441
SG&A to revenue (%): 105.26261134471788
Free cash flow (dilution-adjusted): -25470080
Buyback yield (%): 0
Retained earnings: -231265000
Inventory turnover: 13.275628415300547
Receivables turnover: 0.32217219106555794
Capitalized R&D asset: 9216147.94
ROCI (R&D-adjusted, %): -4.017103241826639
Rosenberg metric: 0.5356470067680983
FCF margin (%): -152.88600082451336
Revenue growth (%): 240.71858908205007
Rule of 40 score: 87.83258825753671
Financial ratios for ASPI — annual report dated 2025-12-31
Total revenue: 23849000
Gross profit: 3405000
Operating income: -57191000
Net income: -159843000
Capital expenditures: 9654000
Operating cash flow: -37780000
Depreciation & amortization: 1912000
Net tangible assets: 194103000
Owner earnings: -167585000
Return on net tangible assets (%): -86.33818127489013
Buffett classification: The Gruesome
Stock price: 5.35
Shares outstanding: 125903447
Book value: 262898000
P/B ratio: 2.562147454335902
Market cap (USD): 673583441.4499999
Debt to equity: 0.8214592731781908
Current ratio: 12.231435037925129
Quick ratio: 12.197852948372889
Interest coverage ratio: -99.46260869565218
COGS to revenue (%): 85.72267181013879
R&D to revenue (%): 51.81768627615414
SG&A to revenue (%): 202.2642458803304
Free cash flow (dilution-adjusted): -63458000
Buyback yield (%): 0
Retained earnings: -231265000
Inventory turnover: 18.619307832422585
Receivables turnover: 0.46120672983948946
Capitalized R&D asset: 14713441.73
ROCI (R&D-adjusted, %): -10.468668197816413
Rosenberg metric: 0.5753424657534246
FCF margin (%): -266.08243532223577
Revenue growth (%): 475.5067567567568
Rule of 40 score: 209.424321434521
Financial ratios for AVX — annual report dated 2021-12-31
Capital expenditures: 1006713
Buffett classification: The Gruesome
Stock price: 1123200
Shares outstanding: 7468018
Market cap (USD): 8388077817600
Buyback yield (%): 0
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for AVX — annual report dated 2022-12-31
Total revenue: 0
Gross profit: 0
Operating income: -13656268
Net income: -12873102
Capital expenditures: 160014
Operating cash flow: -12079359
Depreciation & amortization: 22413
Net tangible assets: -2546724
Owner earnings: -13010703
Buffett classification: The Gruesome
Stock price: 610200
Shares outstanding: 7468018
Book value: 10542653
P/B ratio: 432242.6796746511
Market cap (USD): 4556984583600
Debt to equity: 0.5223909010379076
Current ratio: 0.5440646997210287
Quick ratio: 0.5440646997210287
Interest coverage ratio: -4.0205960234094436
Free cash flow (dilution-adjusted): -13680318
Buyback yield (%): 0
Retained earnings: -32774094
Receivables turnover: 0
Capitalized R&D asset: 615693
ROCI (R&D-adjusted, %): -77.45260577806306
Rule of 40 score: 0
Financial ratios for AVX — annual report dated 2023-12-31
Total revenue: 16281
Gross profit: 2704
Operating income: -9189602
Net income: -11733210
Capital expenditures: 0
Operating cash flow: -6505072
Depreciation & amortization: 679844
Net tangible assets: -4169305
Owner earnings: -11053366
Buffett classification: The Gruesome
Stock price: 5076
Shares outstanding: 7468018
Book value: 8564580
P/B ratio: 4426.096710871987
Market cap (USD): 37907659368
Debt to equity: 0.48221956009518274
Current ratio: 0.6986383625262538
Quick ratio: 0.6922072032558809
Interest coverage ratio: -1.153994343299178
COGS to revenue (%): 83.39168355752103
R&D to revenue (%): 40.47048707081874
SG&A to revenue (%): 48071.07671518948
Free cash flow (dilution-adjusted): -7268298
Buyback yield (%): 0
Retained earnings: -44507304
Inventory turnover: 0.3494093728285766
Receivables turnover: 0.5275932467027448
Capitalized R&D asset: 419103.31
ROCI (R&D-adjusted, %): -79.95238914027476
Rosenberg metric: 0.004391799159646123
FCF margin (%): -44642.822922424915
Rule of 40 score: -44642.822922424915
Financial ratios for AVX — quarterly report dated 2024-09-30
Capital expenditures: 0
Buffett classification: The Gruesome
Stock price: 550.8
Shares outstanding: 7468018
Market cap (USD): 4113384314.3999996
Buyback yield (%): 0
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for AVX — annual report dated 2024-12-31
Total revenue: 26572
Gross profit: -29476
Operating income: -5760026
Net income: -16274815
Capital expenditures: 1513706
Operating cash flow: -5271278
Depreciation & amortization: 667061
Net tangible assets: -1728605
Owner earnings: -17121460
Buffett classification: The Gruesome
Stock price: 255.96
Shares outstanding: 7468018
Book value: 6111253
P/B ratio: 312.78591923456617
Market cap (USD): 1911513887.28
Debt to equity: 0.24297930391688904
Current ratio: 0.2964982472140019
Quick ratio: 0.28667408133528843
Interest coverage ratio: -1.9337239258984222
COGS to revenue (%): 210.92879723016708
R&D to revenue (%): 283.3245521601686
SG&A to revenue (%): 16927.58542827036
Free cash flow (dilution-adjusted): -6870523
Buyback yield (%): 0
Retained earnings: -60782119
Inventory turnover: 1.3205475579011852
Receivables turnover: 0.140318637158141
Capitalized R&D asset: 282878.32
ROCI (R&D-adjusted, %): -87.96816475725919
Rosenberg metric: -4.883897404765518
FCF margin (%): -25856.250940839982
Revenue growth (%): 63.208648117437505
Rule of 40 score: -25793.042292722545
Financial ratios for AVX — quarterly report dated 2024-12-31
Capital expenditures: 0
Buffett classification: The Gruesome
Stock price: 255.96
Shares outstanding: 7468018
Market cap (USD): 1911513887.28
Buyback yield (%): 0
Capitalized R&D asset: 153224
Rule of 40 score: 0
Financial ratios for AVX — quarterly report dated 2025-03-31
Total revenue: 273000
Gross profit: 52000
Operating income: -1766000
Net income: -145000
Capital expenditures: 0
Operating cash flow: -2173000
Depreciation & amortization: 364000
Net tangible assets: -3576775
Owner earnings: 219000
Buffett classification: The Gruesome
Stock price: 118.8
Shares outstanding: 7468018
Book value: 6406986
P/B ratio: 138.47393117450233
Market cap (USD): 887200538.4
Debt to equity: 0.7246474395292888
Current ratio: 0.3386945113480618
Quick ratio: 0.3336895329963221
Interest coverage ratio: -1.8187435633367661
COGS to revenue (%): 80.95238095238095
R&D to revenue (%): 85.4135531135531
SG&A to revenue (%): 539.1941391941392
Free cash flow (dilution-adjusted): -2300000
Buyback yield (%): 0
Retained earnings: -60927574
Inventory turnover: 5.202325745627457
Receivables turnover: 1.3582157125159826
Capitalized R&D asset: 335839.08
ROCI (R&D-adjusted, %): -19.160973394450462
FCF margin (%): -842.4908424908425
Rule of 40 score: -842.4908424908425
Financial ratios for AVX — quarterly report dated 2025-06-30
Total revenue: 451955
Gross profit: 212745
Operating income: -1621023
Net income: -8060242
Capital expenditures: 1024248
Operating cash flow: -883552
Depreciation & amortization: 345032
Net tangible assets: -4925573
Owner earnings: -8739458
Buffett classification: The Gruesome
Stock price: 84.24
Shares outstanding: 7468018
Book value: 4058983
P/B ratio: 154.99100053387758
Market cap (USD): 629105836.3199999
Debt to equity: 2.0247653168293636
Current ratio: 0.12657989639822198
Quick ratio: 0.12604136157071122
Interest coverage ratio: -1.6775844368736315
COGS to revenue (%): 52.927835735858665
R&D to revenue (%): 0
SG&A to revenue (%): 289.83504994966313
Free cash flow (dilution-adjusted): -1989299
Buyback yield (%): 0
Retained earnings: -68987816
Inventory turnover: 40.12917295755746
Receivables turnover: 1.86574773569795
Capitalized R&D asset: 206793.85000000003
ROCI (R&D-adjusted, %): -39.939898330409385
Rosenberg metric: 0.689363107312408
FCF margin (%): -440.1542188934739
Revenue growth (%): 65.55128205128206
Rule of 40 score: -374.60293684219187
Financial ratios for AVX — quarterly report dated 2025-09-30
Total revenue: 525915
Gross profit: 260007
Operating income: -2660157
Net income: -8351326
Capital expenditures: 56100
Operating cash flow: -2377722
Depreciation & amortization: 372943
Net tangible assets: 3366618
Owner earnings: -8034483
Return on net tangible assets (%): -238.65145971417013
Buffett classification: The Gruesome
Stock price: 39
Shares outstanding: 7468018
Book value: 12150539
P/B ratio: 23.970352426340924
Market cap (USD): 291252702
Debt to equity: 0.13904033393086512
Current ratio: 0.6912311138185583
Quick ratio: 0.6898503929530193
Interest coverage ratio: -6.940324558428344
COGS to revenue (%): 50.561022218419325
R&D to revenue (%): -9.153760588688286
SG&A to revenue (%): 404.4564235665459
Free cash flow (dilution-adjusted): -3716147
Buyback yield (%): 0
Retained earnings: -77339142
Inventory turnover: 44.60795168595873
Receivables turnover: 2.138430886209771
Capitalized R&D asset: 28808.070000000007
ROCI (R&D-adjusted, %): -22.66556341583998
FCF margin (%): -706.6060104769782
Revenue growth (%): 16.364461063601464
Rule of 40 score: -690.2415494133768
Financial ratios for AVX — annual report dated 2025-12-31
Total revenue: 2340811
Gross profit: 910144
Operating income: -8059965
Net income: -33195206
Capital expenditures: 6013464
Operating cash flow: -14445853
Depreciation & amortization: 1421674
Net tangible assets: 29811075
Owner earnings: -37786996
Return on net tangible assets (%): -126.7548922673872
Buffett classification: The Gruesome
Stock price: 18.12
Shares outstanding: 7468018
Book value: 186975625
P/B ratio: 0.723733300316552
Market cap (USD): 135320486.16
Debt to equity: 0.0356145085756499
Current ratio: 4.1937290141525585
Quick ratio: 4.1937290141525585
Interest coverage ratio: -2.560289358425549
COGS to revenue (%): 61.11843288501293
R&D to revenue (%): 0.8020297238862941
SG&A to revenue (%): 276.7327648409034
Free cash flow (dilution-adjusted): -132254766
Buyback yield (%): 0.19063188976057105
Retained earnings: -93977325
Receivables turnover: 31.102163110201694
Capitalized R&D asset: 71389.32
ROCI (R&D-adjusted, %): -4.316957617681654
Rosenberg metric: 12.480839476655376
FCF margin (%): -5649.954908790159
Revenue growth (%): 8709.314315821164
Rule of 40 score: 3059.3594070310055
Financial ratios for AVX — quarterly report dated 2025-12-31
Total revenue: 1089687
Gross profit: 387782
Operating income: -2098353
Net income: -16638183
Capital expenditures: 4933116
Operating cash flow: -9011579
Depreciation & amortization: 339699
Net tangible assets: 29811075
Owner earnings: -21231600
Return on net tangible assets (%): -71.22051116908733
Buffett classification: The Gruesome
Stock price: 18.12
Shares outstanding: 7468018
Book value: 186975625
P/B ratio: 0.723733300316552
Market cap (USD): 135320486.16
Debt to equity: 0.0356145085756499
Current ratio: 4.1937290141525585
Quick ratio: 4.1937290141525585
Interest coverage ratio: -2.5368439378057936
COGS to revenue (%): 64.41345083496454
R&D to revenue (%): -9.176947141702158e-05
SG&A to revenue (%): 170.26751718612775
Free cash flow (dilution-adjusted): -124249320
Buyback yield (%): 0
Retained earnings: -93977325
Receivables turnover: 14.47858148866626
Capitalized R&D asset: -32255.47
ROCI (R&D-adjusted, %): -1.1138702976745618
FCF margin (%): -11402.294420324368
Revenue growth (%): 107.19831151421808
Rule of 40 score: -11295.09610881015
Financial ratios for BAK — annual report dated 2021-12-31
Capital expenditures: 0
Buffett classification: The Gruesome
Stock price: 20.33
Shares outstanding: 172530183
Market cap (USD): 3507538620.39
Buyback yield (%): 0
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for BAK — annual report dated 2022-12-31
Total revenue: 18280113636.363636
Gross profit: 2151136363.6363635
Operating income: 1157575757.5757575
Net income: -63636363.63636363
Capital expenditures: 917803030.3030303
Operating cash flow: 1695454545.4545453
Depreciation & amortization: 896401515.1515151
Net tangible assets: 814393939.3939394
Owner earnings: -85037878.78787875
Return on net tangible assets (%): -10.441860465116275
Capex to operating income (%): 79.28664921465969
Buffett classification: The Gruesome
Stock price: 9.2
Shares outstanding: 172530183
Book value: 1156818181.81818
P/B ratio: 1.3721064455481355
Market cap (USD): 1587277683.6
Debt to equity: 8.81221349050427
Current ratio: 1.4246671628214669
Quick ratio: 0.8497064417431571
Effective tax rate (%): 1846.808510638298
Interest coverage ratio: 1.8365384615384617
COGS to revenue (%): 88.23236875641065
R&D to revenue (%): 0.3874884737720034
SG&A to revenue (%): 5.047710813414975
Free cash flow (dilution-adjusted): 777272727.2727273
Buyback yield (%): 0
Inventory turnover: 6.124047173881777
Receivables turnover: 17.523420479302832
Capitalized R&D asset: 70833333.33333333
ROCI (R&D-adjusted, %): 9.902911613763614
FCF margin (%): 4.252012557113107
Rule of 40 score: 4.252012557113107
Financial ratios for BAK — annual report dated 2023-12-31
Total revenue: 14550309278.350517
Gross profit: 622886597.9381443
Operating income: -360824742.26804125
Net income: -944123711.3402063
Capital expenditures: 919175257.7319589
Operating cash flow: -468453608.2474227
Depreciation & amortization: 1073402061.8556702
Net tangible assets: 182268041.23711342
Owner earnings: -789896907.2164949
Return on net tangible assets (%): -433.3710407239819
Buffett classification: The Gruesome
Stock price: 8.82
Shares outstanding: 172530183
Book value: 676082474.2268028
P/B ratio: 2.250784885084176
Market cap (USD): 1521716214.06
Debt to equity: 18.270509301616386
Current ratio: 1.5285784273699683
Quick ratio: 1.0233526577937455
Interest coverage ratio: -0.4117647058823529
COGS to revenue (%): 95.71908345024018
R&D to revenue (%): 0.5427312275928524
SG&A to revenue (%): 6.21802774589409
Free cash flow (dilution-adjusted): -1402474226.8041239
Buyback yield (%): 0
Retained earnings: -564536082.4742268
Inventory turnover: 5.458424242424243
Receivables turnover: 12.536685023982946
Capitalized R&D asset: 126427405.4982818
ROCI (R&D-adjusted, %): -2.3713180889351015
Rosenberg metric: -21.575290809857215
FCF margin (%): -9.638793237823974
Revenue growth (%): -20.40361691512476
Rule of 40 score: -30.042410152948733
Financial ratios for BAK — quarterly report dated 2024-09-30
Operating income: 187661141.80478823
Capital expenditures: 0
Capex to operating income (%): 0
Buffett classification: The Great
Stock price: 7.34
Shares outstanding: 172530183
Market cap (USD): 1266371543.22
Buyback yield (%): 0
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for BAK — annual report dated 2024-12-31
Total revenue: 12526051779.935276
Gross profit: 970388349.5145632
Operating income: -160194174.75728157
Net income: -1831715210.355987
Capital expenditures: 599352750.8090615
Operating cash flow: 394012944.98381877
Depreciation & amortization: 800970873.7864078
Net tangible assets: -1321844660.1941748
Owner earnings: -1630097087.3786407
Buffett classification: The Gruesome
Stock price: 3.86
Shares outstanding: 172530183
Book value: -692233009.7087383
Market cap (USD): 665966506.38
Debt to equity: -17.23281907433379
Current ratio: 1.310024052065648
Quick ratio: 0.8335101867572157
Interest coverage ratio: -0.1820857090307155
COGS to revenue (%): 92.25303897378926
R&D to revenue (%): 0.5981062122954103
SG&A to revenue (%): 5.981062122954102
Free cash flow (dilution-adjusted): -214401294.49838188
Buyback yield (%): 0
Retained earnings: -2270873786.4077673
Inventory turnover: 5.300920427553444
Receivables turnover: 11.902060270602705
Capitalized R&D asset: 151203372.20164818
ROCI (R&D-adjusted, %): -1.333459681252977
Rosenberg metric: 4.400479099596948
FCF margin (%): -1.7116430481456124
Revenue growth (%): -13.912126949955248
Rule of 40 score: -15.62376999810086
Financial ratios for BAK — quarterly report dated 2024-12-31
Capital expenditures: 0
Buffett classification: The Gruesome
Stock price: 3.86
Shares outstanding: 172530183
Market cap (USD): 665966506.38
Buyback yield (%): 0
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for BAK — quarterly report dated 2025-03-31
Total revenue: 3924131944.4444447
Gross profit: 227430555.55555555
Operating income: 173611.11111111112
Net income: 121180555.55555557
Capital expenditures: 113368055.55555557
Operating cash flow: -404861111.1111111
Depreciation & amortization: 206770833.33333334
Net tangible assets: -1311284722.2222223
Owner earnings: 214583333.3333333
Return on net tangible assets (%): -16.36435853303323
Capex to operating income (%): 65300
Buffett classification: The Gruesome
Stock price: 3.85
P/E ratio: 1.370354347495702
Shares outstanding: 172530183
Book value: -658854166.666666
Market cap (USD): 664241204.5500001
Debt to equity: -18.17549407114626
Current ratio: 1.3165900930466004
Quick ratio: 0.767113238871086
Effective tax rate (%): 22.549019607843135
Interest coverage ratio: 0.0007722007722007722
COGS to revenue (%): 80.29907534398089
R&D to revenue (%): 0.5574481263549086
SG&A to revenue (%): 5.233818519665531
Free cash flow (dilution-adjusted): -518229166.6666667
Buyback yield (%): 0
Retained earnings: -2314756944.4444447
Inventory turnover: 1.2752951096121417
Receivables turnover: 3.556726986624705
Capitalized R&D asset: 21875000
ROCI (R&D-adjusted, %): 0.1220440219966402
FCF margin (%): -13.206211564836526
Rule of 40 score: -13.206211564836526
Financial ratios for BAK — quarterly report dated 2025-06-30
Total revenue: 3258576642.3357663
Gross profit: 66058394.160583936
Operating income: -174817518.24817517
Net income: -48722627.73722627
Capital expenditures: 118248175.18248174
Operating cash flow: -52007299.27007299
Depreciation & amortization: 225729927.00729924
Net tangible assets: -1279744525.547445
Owner earnings: 58759124.08759123
Buffett classification: The Gruesome
Stock price: 3.28
P/E ratio: 7.810035661782305
Shares outstanding: 172530183
Book value: -594525547.4452553
Market cap (USD): 565899000.24
Debt to equity: -20.064456721915292
Current ratio: 1.206980487613364
Quick ratio: 0.6847395076753955
Interest coverage ratio: -0.5792019347037485
COGS to revenue (%): 97.97278378227026
R&D to revenue (%): 0.6048048384387076
SG&A to revenue (%): 6.787254298034384
Free cash flow (dilution-adjusted): -170255474.45255473
Buyback yield (%): 0
Retained earnings: -2481204379.5620437
Inventory turnover: 1.3152157570290182
Receivables turnover: 2.665223880597015
Capitalized R&D asset: 34364279.19708029
ROCI (R&D-adjusted, %): -1.4025354404953088
Rosenberg metric: -7.377013092341559
FCF margin (%): -5.22484179873439
Revenue growth (%): -16.96057399524836
Rule of 40 score: -22.18541579398275
Financial ratios for BAK — quarterly report dated 2025-09-30
Total revenue: 3251691729.323308
Gross profit: 81954887.21804512
Operating income: -150000000
Net income: -4887218.045112782
Capital expenditures: 238345864.6616541
Operating cash flow: -128383458.64661653
Depreciation & amortization: 203947368.42105263
Net tangible assets: -1234586466.1654134
Owner earnings: -39285714.28571427
Buffett classification: The Gruesome
Stock price: 2.42
P/E ratio: 6.179053679638815
Shares outstanding: 172530183
Book value: -596428571.4285717
Market cap (USD): 417523042.86
Debt to equity: -19.929719508351706
Current ratio: 1.1754205440229062
Quick ratio: 0.6317108088761632
Interest coverage ratio: -0.49906191369606007
COGS to revenue (%): 97.47962309960113
R&D to revenue (%): 0.6994623966703278
SG&A to revenue (%): 6.433897913174172
Free cash flow (dilution-adjusted): -366729323.30827063
Buyback yield (%): 0
Retained earnings: -2560338345.8646617
Inventory turnover: 1.3875586274993827
Receivables turnover: 2.903978512674165
Capitalized R&D asset: 43167490.46429944
ROCI (R&D-adjusted, %): -1.2121759320363648
Rosenberg metric: 0.8065998329156229
FCF margin (%): -11.278108561188507
Revenue growth (%): -0.21128590081352758
Rule of 40 score: -11.489394462002034
Financial ratios for BAK — annual report dated 2025-12-31
Total revenue: 12904562043.79562
Gross profit: 283941605.839416
Operating income: -299635036.49635035
Net income: -1802919708.029197
Capital expenditures: 571532846.7153285
Operating cash flow: -766423357.6642336
Depreciation & amortization: 852737226.2773722
Net tangible assets: -3505474452.5547442
Owner earnings: -1521715328.467153
Buffett classification: The Gruesome
Stock price: 2.95
Shares outstanding: 172530183
Book value: -3011313868.613138
Market cap (USD): 508964039.85
Debt to equity: -4.321657980850806
Current ratio: 0.7570739469889104
Quick ratio: 0.49796111193992737
Interest coverage ratio: -0.3127619047619048
COGS to revenue (%): 97.79968041630724
R&D to revenue (%): 0.6504800825826887
SG&A to revenue (%): 6.620755970982932
Free cash flow (dilution-adjusted): -1337956204.379562
Buyback yield (%): 0
Retained earnings: -4361678832.116788
Inventory turnover: 6.636695134823913
Receivables turnover: 9.037316293929713
Capitalized R&D asset: 160197192.53410795
ROCI (R&D-adjusted, %): -3.799901862053434
Rosenberg metric: -9.162507291387493
FCF margin (%): -10.368086881513639
Revenue growth (%): 3.0217842821523107
Rule of 40 score: -7.346302599361328